Display options
Share it on

Vaccines (Basel). 2021 Dec 01;9(12). doi: 10.3390/vaccines9121419.

Comirnaty-Elicited and Convalescent Sera Recognize Different Spike Epitopes.

Vaccines

Sascha Hein, Nuka Ivalu Benz, Jonathan Eisert, Marie-Luise Herrlein, Doris Oberle, Michael Dreher, Julia C Stingl, Christoph Hildt, Eberhard Hildt

Affiliations

  1. Department of Virology, Paul-Ehrlich-Institut, Paul-Ehrlich Street 51-59, D-63225 Langen, Germany.
  2. Division of Pharmacovigilance, Paul-Ehrlich-Institut, Paul-Ehrlich Street 51-59, D-63325 Langen, Germany.
  3. Department of Pneumology and Intensive Care Medicine, RWTH Aachen University Hospital Aachen, Pauwelsstraße 30, D-52074 Aachen, Germany.
  4. Institute of Clinical Pharmacology, RWTH Aachen University Hospital Aachen, Pauwelsstraße 30, D-52074 Aachen, Germany.
  5. Main-Kinzig-Kliniken, Herzbachweg 14, D-63571 Gelnhausen, Germany.

PMID: 34960165 PMCID: PMC8708883 DOI: 10.3390/vaccines9121419

Abstract

Many of the approved SARS-CoV-2 vaccines are based on a stabilized variant of the spike protein. This raises the question of whether the immune response against the stabilized spike is identical to the immune response that is elicited by the native spike in the case of a SARS-CoV-2 infection. Using a peptide array-based approach, we analysed the binding of antibodies from Comirnaty-elicited, convalescent, and control sera to the peptides covering the spike protein. A total of 37 linear epitopes were identified. A total of 26 of these epitopes were almost exclusively recognized by the convalescent sera. Mapping these epitopes to the spike structures revealed that most of these 26 epitopes are masked in the pre-fusion structure. In particular, in the conserved central helix, three epitopes that are only exposed in the post-fusion conformation were identified. This indicates a higher spike-specific antibody diversity in convalescent sera. These differences could be relevant for the breadth of spike-specific immune response.

Keywords: SARS-CoV-2 spike; convalescent; linear epitopes; peptide array; stabilized spike protein

References

  1. NPJ Vaccines. 2021 Aug 16;6(1):104 - PubMed
  2. Proc Natl Acad Sci U S A. 2017 Aug 29;114(35):E7348-E7357 - PubMed
  3. Int Arch Allergy Immunol. 2015;166(3):213-24 - PubMed
  4. Nat Med. 2020 Jul;26(7):1033-1036 - PubMed
  5. Commun Biol. 2021 Feb 12;4(1):225 - PubMed
  6. Cell Host Microbe. 2021 May 12;29(5):819-833.e7 - PubMed
  7. Science. 2020 Nov 27;370(6520): - PubMed
  8. Structure. 2020 Nov 3;28(11):1218-1224.e4 - PubMed
  9. Allergy. 2021 Oct 12;: - PubMed
  10. Emerg Microbes Infect. 2020 Dec;9(1):680-686 - PubMed
  11. Sci Rep. 2021 Mar 10;11(1):5558 - PubMed
  12. BMC Microbiol. 2021 Jun 26;21(1):194 - PubMed
  13. Cell. 2020 Apr 16;181(2):281-292.e6 - PubMed
  14. Vaccines (Basel). 2021 Jan 11;9(1): - PubMed
  15. Science. 2020 Nov 20;370(6519):950-957 - PubMed
  16. J Biol Chem. 2021 Jan-Jun;296:100111 - PubMed
  17. Eur J Immunol. 2021 Jul;51(7):1839-1849 - PubMed
  18. Diagnostics (Basel). 2021 May 30;11(6): - PubMed
  19. Antiviral Res. 2020 Apr;176:104742 - PubMed
  20. Nat Commun. 2021 Feb 19;12(1):1152 - PubMed
  21. Cell Rep. 2021 Mar 30;34(13):108915 - PubMed
  22. J Biomed Sci. 2008 Nov;15(6):707-17 - PubMed
  23. Nature. 2021 Apr;592(7853):277-282 - PubMed
  24. Nat Commun. 2020 Jul 17;11(1):3618 - PubMed
  25. Cell. 2020 Nov 12;183(4):1024-1042.e21 - PubMed
  26. Nature. 2020 May;581(7807):215-220 - PubMed
  27. J Virol. 2021 Apr 12;95(9): - PubMed
  28. Sci Rep. 2018 Oct 24;8(1):15701 - PubMed

Publication Types

Grant support